Cognitive and Memory Enhancer Drugs Market to Approach $6,598 million by 2023 with Key Players: Pfizer Inc., Eisai Co., Ltd., Allergan, Inc., Novartis AG and More
Most of the college students, professionals, and entrepreneurs are using smart drugs to maximize their mental capabilities. For instance, Piracetam improves memory in seniors experiencing age-related mental decline or dementia. These benefits of smart drugs are expected to propel the market growth for cognitive and memory enhancer drugs.
The Asia-Pacific market is projected to grow at the highest CAGR of 9.6% during the forecast period, owing to improvement in healthcare infrastructure and rise in expenditures in the emerging markets (such as India and China) to cater to the unmet medical needs.
The major companies profiled in the report are Pfizer Inc., Eisai Co., Ltd., Allergan, Inc., Novartis AG, Shire, Johnson & Johnson, Takeda Pharmaceutical Company Limited, AlternaScript LLC, Cephalon, Inc. (Teva Pharmaceutical Industries Ltd.), and Ceretropic.
Cognitive and memory enhancers are the drugs or supplements, which help to improve the cognitive functions such as memory, creativity, and others in patients suffering from diseases such as neurological disorders as well as in healthy individuals. The major factors that contribute to the market growth include growth in geriatric population prone to neurological disorders such as Alzheimer. Moreover, rise in adoption of cognitive drugs owing to its benefits such as improved physical and mental performance boosts the market growth. However, the ethical issues related with the use of such drugs restrain the growth of this market.
Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4556
Namenda generated the maximum revenue in the global cognitive and memory enhancer drugs market in 2016, and is expected to dominate the market till 2023. Exelon segment is expected to register the highest CAGR of 10.9% during the forecast period, owing to increase in awareness among people towards improved physical performance.
Disease treatment application segment is expected to dominate the market in the future, owing to increase in the number of patients suffering from neurological diseases such as Alzheimer's. On the other hand, academic performance segment is estimated to exhibit a CAGR of 10.2% during the forecast period.
Key Benefits for Stakeholders
• The study provides an in-depth analysis of the global cognitive and memory enhancer drugs market, with current trends and future estimations to elucidate the imminent investment pockets.
• Quantitative analysis from 2016 to 2023 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
• Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cognitive and Memory Enhancer Drugs Market to Approach $6,598 million by 2023 with Key Players: Pfizer Inc., Eisai Co., Ltd., Allergan, Inc., Novartis AG and More here
News-ID: 1701144 • Views: 267
More Releases from Allied Market Research
North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently
More Releases for Cognitive
Cognitive Computing: Applications and Global Markets
Cognitive computing like many IT terms is defined both by its technical capability and applications and by marketing statements. From a technical standpoint, cognitive computing is a system that uses machine learning algorithms to continually increase its knowledge from the data it receives. The learning aspect is characterized by the system continuously refining patterns in the data as well as the way data is processed. This learning allows cognitive computing
Cognitive Services – Global Market Outlook (2018-2025)
Global Cognitive Services Industry New Study On “2018-2025 Cognitive Services Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database This report focuses on the global Cognitive Services status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cognitive Services development in United States, Europe and China. Cognitive Services are a set of machine learning algorithms that Microsoft has developed
Global Cognitive Analytics Market- The Thematic Research
Cognitive Analytics.jpgSummary:- (Cognitive Analytics) Global Cognitive Analytics report, the Cognitive Analytics is expected to reach a value of $1.95 billion in 2017 and is projected to reach a value of $40.25 billion at the end of 2027. The global Cognitive Analytics report covers the Cognitive Analytics in a comprehensive manner, across all parameters such as types, applications, users, top players, and regions. The report further covers the drivers, restraints and trends
Global Cancer Cognitive Computing Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title Global Cancer Cognitive Computing Market Outlook 2022 to its growing collection of premium market research reports. The emergence of Cognitive Computing for Cancer has revolutionized the healthcare industry. This technique is allowing a previously unattainable level of personalized treatment options with efficiency and simplicity. Due to this ability, it is anticipated that the Global Cancer Cognitive Computing market will cross US$
Cognitive Computing Market: Lucrative Opportunity by 2025
Data analysis can yield dramatic and yet highly dependable results. In recent times, almost every organization, big or small, is resorting to computation for certain kind in order to enhance their production efficiency, meet the demand coming from consumers, and counter the challenge posed by local and global competitors. Cognitive computing relates to next stage of data analysis wherein it not only crunches all the available data to make a
Global Cognitive Computing Market
In the ever changing world of information technology, business organizations are left with humongous amount of data with them. This data includes very critical information for business use, but business organizations are only able to utilize 20% of whole data available with them with the use of traditional data analytics technology. To process and interpret the reaming 80% of the data that is in the form of videos, images, and